George Church, Ph.D.Dr. George Church, PhD. is Professor of Genetics at Harvard Medical School and Director of the Center for Computational Genetics. He completed his PhD at Harvard in Biochemistry & Molecular Biology with Walter Gilbert, developing the first direct genomic sequencing method in 1984. In that year he helped initiate the Human Genome Project. He was then a Research Scientist at newly-formed Biogen Inc. and a Monsanto Life Sciences Research Fellow at UCSF. Dr. Church later helped to found the Stanford, MIT, and Waltham Genome Centers. He invented the broadly applied concepts of molecular multiplexing and tags, homologous recombination methods, and array DNA synthesizers. Technology transfer of automated sequencing and annotation software to Genome Therapeutics Corp. resulted in the first genome sequence sold commercially (the human pathogen, H. pylori). His innovations in genomics, computational biology, genetics and systems biology have been the basis for a number of companies. Dr. Church's research focuses on integrating biosystems modeling with high-throughput data for haplotypes, RNA arrays, proteomics, and metabolites.
Jorge C. Conde
Jorge Conde is President and CEO of Knome, Inc. He has spent his entire professional career in the biotechnology industry, working in finance, business development, marketing and operations. Prior to Knome, Mr. Conde worked in strategic marketing and operations at MedImmune, Inc. He has also worked in business development at Helicos Biosciences Corporation, a DNA sequencing company, and in the life sciences group at Flagship Ventures, a venture capital firm. Previously, Mr. Conde was an investment banker at Morgan Stanley & Co., specializing in the biotechnology and genomics industries. He holds an MBA from Harvard Business School, an MS from the Harvard-MIT Division of Health Sciences and Technology (HST) and a Bachelor's degree in Biology from The Johns Hopkins University.
Jonas Lee Jonas Lee is managing partner of Redbrick Partners. He has founded and managed several start-ups in finance, Internet retailing and technology that pioneered new markets and technologies, including Redbrick Partners, GiftCertificates.com and Integrated Computing Engines. Prior to his entrepreneurial activities, Mr. Lee served as a management consultant with Bain & Company. He is a graduate of Harvard Business School and Brandeis University.
Anthony J. Sinskey Ph.D.Dr. Anthony Sinskey, Ph.D. is professor of Microbiology and Health Sciences and Technology at the Massachusetts Institute of Technology (MIT). He is widely recognized for pioneering multidisciplinary approaches to solve problems. Professor Sinskey has participated in the founding and development of over 15 biotechnology companies over the course of two decades, including Metabolix and Genzyme, Merrimack Pharmaceuticals, and Tepha, a medical device company. One of his current areas of research focuses on understand how technological innovations in basic sciences and systems biology can facilitate pharmaceutical drug development in personalized medicine.
Sundar SubramaniamSundar Subramaniam is the Chairman of Cell Exchange. He has founded eight successful IT companies, five of which completed IPOs. Mr. Subramaniam also served as Chairman of I-Cube, C-bridge, Open Environment Corporation, Worldstreet Corporation, Integrated Computing Engines, and as Managing Director of Cambridge Samsung Partners, a Venture Capital firm. Mr. Subramaniam completed his Bachelor of Science in Economics and Computer Science from Brandeis University and an MS from the Harvard-MIT Division of Health Sciences and Technology (HST).